BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2230653)

  • 21. [Formation of Langerhans granules seems linked to membrane ATPase activity of epidermal Langerhans cells].
    Hanau D; Fabre M; Lepoittevin JP; Stampf JL; Grosshans E; Benezra C
    C R Acad Sci III; 1985; 301(5):167-72. PubMed ID: 2933132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells.
    Aberer W; Kruisbeek AM; Shimada S; Katz SI
    J Immunol; 1986 Feb; 136(3):830-6. PubMed ID: 3455705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of murine epidermal Langerhans cells with spleen dendritic cells.
    Schuler G; Romani N; Steinman RM
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):99s-106s. PubMed ID: 3159809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen processing and presentation by epidermal Langerhans cells. Induction of immunity or unresponsiveness.
    Cruz PD; Bergstresser PR
    Dermatol Clin; 1990 Oct; 8(4):633-47. PubMed ID: 1979019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective enrichment of murine epidermal Langerhans cells by a modified(mismatched) panning technique.
    Koch F; Kämpgen E; Schuler G; Romani N
    J Invest Dermatol; 1992 Dec; 99(6):803-7. PubMed ID: 1469295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunophenotypic characterization of feline Langerhans cells.
    Saint-André Marchal I; Dezutter-Dambuyant C; Willett BJ; Woo JC; Moore PF; Magnol JP; Schmitt D; Marchal T
    Vet Immunol Immunopathol; 1997 Aug; 58(1):1-16. PubMed ID: 9343335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Essential Role of anxA2 in Langerhans Cell Birbeck Granules Formation.
    Thornton SM; Samararatne VD; Skeate JG; Buser C; Lühen KP; Taylor JR; Da Silva DM; Kast WM
    Cells; 2020 Apr; 9(4):. PubMed ID: 32326440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation between langerhans cells, veiled cells, and interdigitating cells.
    Hoefsmit EC; Duijvestijn AM; Kamperdijk EW
    Immunobiology; 1982 Apr; 161(3-4):255-65. PubMed ID: 7047373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Appearance of Birbeck granule-like structures in anti-T6 antibody-treated human epidermal Langerhans cells.
    Hanau D; Fabre M; Schmitt DA; Garaud JC; Pauly G; Cazenave JP
    J Invest Dermatol; 1988 Mar; 90(3):298-304. PubMed ID: 3258000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Derivation of Langerhans cell granules from cytomembrane.
    Takahashi S; Hashimoto K
    J Invest Dermatol; 1985 Jun; 84(6):469-71. PubMed ID: 2582062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrastructural similarities between epidermal Langerhans cell Birbeck granules and the surface-connected canalicular system of EDTA-treated human blood platelets.
    Hanau D; Gachet C; Schmitt DA; Ohlmann P; Brisson C; Fabre M; Cazenave JP
    J Invest Dermatol; 1991 Nov; 97(5):756-62. PubMed ID: 1919041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes.
    Inaba K; Schuler G; Witmer MD; Valinksy J; Atassi B; Steinman RM
    J Exp Med; 1986 Aug; 164(2):605-13. PubMed ID: 3487618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Langerhans' cells in urticaria: an electron microscopic study.
    Michalowski R
    Indian J Dermatol; 1989 Sep; 34(3):54-8. PubMed ID: 2632378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fresh and cultured Langerhans cells display differential capacities to activate hapten-specific T cells.
    Dai R; Grammer SF; Streilein JW
    J Immunol; 1993 Jan; 150(1):59-66. PubMed ID: 8417131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunostimulatory capabilities of highly enriched Langerhans cells in vitro.
    Picut CA; Lee CS; Dougherty EP; Anderson KL; Lewis RM
    J Invest Dermatol; 1988 Feb; 90(2):201-6. PubMed ID: 3257515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation and expansion of hapten- and protein-specific T helper cells from nonsensitized mice.
    Hauser C; Katz SI
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5625-8. PubMed ID: 2969593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical properties of MHC class II molecules endogenously synthesized and expressed by mouse Langerhans cells.
    Becker D; Reske-Kunz AB; Knop J; Reske K
    Eur J Immunol; 1991 May; 21(5):1213-20. PubMed ID: 2037010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MHC class II expression by Langerhans' cells and lymph node dendritic cells: possible evidence for maturation of Langerhans' cells following contact sensitization.
    Cumberbatch M; Gould SJ; Peters SW; Kimber I
    Immunology; 1991 Nov; 74(3):414-9. PubMed ID: 1769690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal cells as accessory cells in the generation of allo-reactive and hapten-specific cytotoxic T lymphocyte (CTL) responses.
    Steiner G; Wolff K; Pehamberger H; Stingl G
    J Immunol; 1985 Feb; 134(2):736-41. PubMed ID: 2578162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.